Respiratory community calls for lung testing to be offered as 'standard'
As leading figures in respiratory health from across the globe gather in Birmingham for the COPD8 conference ahead of World Spirometry Day, the European COPD Coalition (ECC) is calling on policy makers across Europe to recognise that chronic diseases such as COPD, present as great a threat as the global financial crisis, and is urging collective action.
To support this, several West Midlands NHS Foundation Trusts will be offering free public spirometry, the most effective test of lung heath, in Birmingham as the ECC asks Members of the European Parliament (MEPs) to make lung testing a basic health right for all across Europe and to place greater emphasis on training for healthcare professionals.
With lung diseases now the leading cause of death globally, mortality due to COPD has doubled in the last three decades and is furthermore projected to increase by more than 30 per cent in the next 10 years worldwide without interventions to cut risks . Regular and early lung testing would help people identify the debilitating condition before too much damage is done; giving them a chance to slow the disease's progression before it completely ruins their lung function. However, with COPD still underdiagnosed in 75% of cases, research amongst healthcare professionals suggests spirometry is either not being used or is being used ineffectively, leading to inaccurate results .
According to ECC, better testing promises to reduce the significant burden of COPD, which is currently costing the individual health services across the EU in excess of 8 billion euros every year. They argue that more needs to be done to ensure healthcare professionals are educated and trained both to provide and to accurately interpret, spirometry tests. Funding needs to be made available to allow this to happen.
Heralding England as an exemplar, with its action plan on COPD , the ECC also pointed to the dearth of health promotion activity to drive awareness of COPD across Europe and to the very limited investment in research on COPD. According to the latest data, considerably less money is devoted to research on respiratory diseases in most European countries than the impact of the condition justifies. What's more, only a tenth of the budget currently dedicated to respiratory diseases goes to asthma and COPD, despite these posing the most significant challenge .